国新证券股份有限公司 关于安徽皖仪科技股份有限公司 使用暂时闲置募集资金进行现金管理的核查意见 经中国证券监督管理委员会《关于同意安徽皖仪科技股份有限公司首次公开发行股 票注册的批复》(证监许可【2020】999号)核准,公司向社会公众公开发行人民币普 通股(A 股) 3.334万股,每股面值 1.00元,每股发行价格为 15.50元,本次公开发行 募集资金总额为 51,677.00 万元,扣除总发行费用 5.846.76 万元(不含增值税),募集资 金净额为 45,830.24 万元。上述募集资金到位情况已经容诚会计师事务所(特殊普通合 伙) 审验,并于 2020年 6月 30日出具了"容诚验字[2020]230Z0109 号"《验资报告》。 公司对募集资金采取了专户存储制度,设立了相关募集资金专项账户,募集资金到 账后,已全部存放于该募集资金专项账户内,并与保荐机构、存放募集资金的银行签署 了募集资金三方监管协议。具体情况详见 2020年7月2日披露于上海证券交易所网站 (www.sse.com.cn) 首次公开发行股票科创板上市公告书。 二、募集资金使用情况 根据公司披露的《安徽皖仪科技股份有限公司首次 ...

安徽皖仪科技股份有限公司 关于使用暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 安徽皖仪科技股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日召开 了第六届董事会第二次会议，审议通过了《关于使用暂时闲置募集资金进行现金 管理的议案》，同意公司在保证不影响募集资金投资项目实施、确保募集资金安 全的前提下，使用最高不超过人民币 15,000 万元的暂时闲置募集资金进行现金 管理，用于购买安全性高、流动性好、有保本约定的投资产品（包括但不限于结 构性存款、协议存单、通知存款、定期存款、大额存单等），使用期限不超过 12 个月，在前述额度及期限范围内，公司可以循环滚动使用。公司董事会授权总经 理在前述额度及决议有效期内行使投资决策权、签署相关文件等事宜，具体事项 由公司财务中心负责组织实施。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意安徽皖仪科技股份有限公司首次公开 发行股票注册的批复》（证监许可【2020】999 号）核准，公司向社会公众公开 发行人民币普通股（ ...

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].

近日，安徽皖仪科技股份有限公司（以下简称"公司"）收到国新证券股份 有限公司（以下简称"国新证券"）出具的《关于变更安徽皖仪科技股份有限公 司持续督导保荐代表人的函》，国新证券原指派肖扬女士、张展先生作为保荐代 表人负责持续督导工作。截至 2023 年 12 月 31 日，公司首次公开发行股票并上 市的法定持续督导期已届满，由于募集资金尚未使用完毕，国新证券仍需对公司 募集资金的使用情况履行持续督导义务。 证券代码：688600 证券简称：皖仪科技 公告编号：2025-054 安徽皖仪科技股份有限公司 关于变更持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 安徽皖仪科技股份有限公司董事会 2025 年 6 月 28 日 附件：乔军文先生简历 乔军文先生，男，保荐代表人、注册会计师、资产评估师，现任国新证券投 资银行部总经理。曾先后主持并参与北纬通信（002148）、明泰铝业（601677）、 天汽模（002510）、京北方（002987）、元道通信（301139）等项目的首次公开发 行工作；先后主 ...

Group 1 - Wanyi Technology and Hefei Comprehensive National Science Center Energy Research Institute signed an agreement to establish a joint laboratory for the research and development of key vacuum measurement equipment for nuclear fusion [1] - The joint laboratory will focus on developing tritium-compatible leak detection technology and vacuum measurement equipment resistant to neutron radiation and electromagnetic interference [1] - This collaboration is expected to accelerate the development of the domestic vacuum equipment industry and enhance Wanyi Technology's competitive advantage in the nuclear fusion sector [1] Group 2 - Dangsheng Technology has developed high ionic conductivity sulfide solid electrolytes with controllable micro-nano particle sizes, achieving stable production and scalability [2] - Multiple electrolyte products have received certification and integration from leading battery manufacturers and automotive companies, indicating a significant breakthrough in solid-state electrolyte technology [2] - This advancement is expected to improve battery performance and accelerate the development of the electric vehicle industry, solidifying Dangsheng Technology's leading position in the market [2] Group 3 - JinkoSolar's subsidiary achieved a record conversion efficiency of 27.02% for its 182N-type high-efficiency monocrystalline silicon cells, certified by a third-party testing center [3] - The N-type TOPCon high-efficiency photovoltaic modules also received certification, with a maximum conversion efficiency of 25.58%, setting a new record for similar products globally [3] - These breakthroughs in conversion efficiency highlight JinkoSolar's innovation capabilities and are expected to enhance the competitiveness of its products, promoting the adoption of solar energy and contributing to global energy transition [3]

Core Viewpoint - The signing of the cooperation agreement between Anhui Wanyi Technology Co., Ltd. and Hefei Comprehensive National Science Center Energy Research Institute marks the establishment of a joint laboratory aimed at advancing domestic vacuum technology and equipment industry, particularly in the field of nuclear fusion vacuum measurement [1][2]. Agreement Overview - The agreement was signed on June 22, 2025, at Wanyi Technology, and it does not require board or shareholder approval as it is not classified as a related party transaction or a major asset restructuring [2][3]. - The Energy Research Institute focuses on major scientific tasks and the construction of national large-scale scientific infrastructure, with key research areas including clean coal utilization, magnetic confinement fusion, renewable energy, and smart power grids [2][3]. Joint Laboratory Details - The joint laboratory will be established to facilitate deep integration in research and demand, technology and market, talent and industry, following principles of mutual benefit and resource sharing [3][4]. - Wanyi Technology plans to invest a total of 4 million RMB in research and development, while the Energy Research Institute will contribute 2 million RMB, matching 50% of Wanyi Technology's investment [4]. Impact on the Company - The agreement is expected to enhance the company's product advantages, brand influence, and core competitiveness, aligning with its long-term strategic development goals [4]. - The signing of the agreement will not alter the company's main business or operational scope, ensuring the company's independence and protecting shareholder interests [4].

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

安徽皖仪科技股份有限公司 关于自愿披露签署联合实验室共建协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本协议的签署仅代表双方确立了合作关系，后续具体合作细节有待进一步 商讨，实施进度和执行情况尚存在不确定性。 证券代码：688600 证券简称：皖仪科技 公告编号：2025-053 （二）关联关系说明 本协议的签署不构成关联交易，亦不构成重大资产重组，未触及公司董事会 及股东会审议标准。为便于投资者作出价值判断和投资决策，公司对本协议签署情 况进行自愿性披露。 公司将根据合作具体事项的后续进展，按照相关法律法规及《公司章程》的 规定，履行相应的审批程序和信息披露义务。 公司与能源研究院不存在关联关系。 相关风险提示：研发过程可能受限于部分技术瓶颈或因技术迭代导致无法达 到预期性研发目标的风险，敬请广大投资者注意投资风险。 近日，安徽皖仪科技股份有限公司（以下简称"公司"或"皖仪科技"）与合肥 综合性国家科学中心能源研究院（以下简称"能源研究院"）经友好协商，达成合作 意向，并签署了《联合实验室共 ...

Core Viewpoint - The company, Anhui Yi Technology (皖仪科技), has signed a joint laboratory agreement with the Energy Research Institute to establish a research lab focused on key vacuum measurement equipment for nuclear fusion, aiming to advance domestic vacuum technology and equipment industry [1] Group 1 - The joint laboratory will be named "Joint Laboratory for R&D of Key Vacuum Measurement Equipment for Nuclear Fusion" [1] - Anhui Yi Technology plans to invest 4 million yuan in research and development, while the Energy Research Institute will contribute 50% of the funding [1] - The agreement does not constitute a related party transaction or a major asset restructuring, and does not require approval from the company's board or shareholders [1]

Group 1: Company Research - Wan Yi Technology - Wan Yi Technology's main business includes industrial testing instruments, online monitoring instruments, laboratory analysis instruments, and medical instruments [1] - The company provides high-precision vacuum leak detection solutions in the nuclear fusion field, with its helium mass spectrometer reaching an internationally advanced level [1] - The development of blood dialysis equipment is progressing smoothly, with plans to submit registration applications to the National Medical Products Administration by the end of 2025 [1] - The company is enhancing profitability through improved cost and expense management [1] Group 2: Company Research - Tao Tao Vehicle - Tao Tao Vehicle's production capacity in Vietnam is expected to significantly increase, with electric golf cart production reaching new highs in June and continuing to rise in July [2] - The expansion of overseas production capacity in Southeast Asia and the U.S. is a strategic response to international trade friction, enhancing competitiveness in the U.S. market [2] - The company is well-prepared to address market shifts, benefiting from the loss of some domestic manufacturers in the U.S. market [2] Group 3: Company Overview - Xing Shi Investment - Xing Shi Investment, established in 2007, is one of China's top private equity investment management firms and a pioneer in the industry [3] - The firm has received numerous awards, including the "Morningstar China Hedge Fund Award" and the "China Private Equity Golden Bull Award," showcasing its strong investment capabilities [3] - The investment team, led by Jiang Hui, has extensive experience and has consistently delivered stable performance through various market cycles [3] - Xing Shi Investment employs a multi-layered driving factor investment approach, focusing on comprehensive research across categories, industries, and companies to identify strong investment opportunities [3]